NasdaqGS - Delayed Quote USD
PTC Therapeutics, Inc. (PTCT)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 5:16 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 21,650 | 2 |
Sales | 22,444 | 3 |
Net Shares Purchased (Sold) | -794 | 5 |
Total Insider Shares Held | 1.81M | -- |
% Net Shares Purchased (Sold) | -0.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
GRAVIER PIERRE Chief Financial Officer | Sale at price 34.02 per share. | Direct | 77,200 | Jul 16, 2024 |
ZELDIS JEROME B. M.D., PH.D. Director | Conversion of Exercise of derivative security at price 26.42 per share. | Direct | 528,400 | May 22, 2024 |
ZELDIS JEROME B. M.D., PH.D. Director | Sale at price 38.24 per share. | Direct | 764,800 | May 22, 2024 |
SOUTHWELL DAVID P Director | Stock Gift at price 0.00 per share. | Direct | 0 | May 8, 2024 |
GOLDEN LEE SCOTT Officer | Sale at price 32.82 per share. | Direct | 5,744 | May 7, 2024 |
KLEIN MATTHEW B Chief Executive Officer | Sale at price 24.89 per share. | Direct | 83,669 | Apr 19, 2024 |
PAUWELS ERIC Chief Executive Officer | Sale at price 25.14 per share. | Direct | 19,781 | Apr 17, 2024 |
KLEIN MATTHEW B Chief Executive Officer | Sale at price 25.14 per share. | Direct | 32,851 | Apr 17, 2024 |
GOLDEN LEE SCOTT Officer | Sale at price 28.37 per share. | Direct | 14,923 | Apr 2, 2024 |
REEVE EMMA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
GOLDEN LEE SCOTT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
UTTER CHRISTINE MARIE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
OKEY STEPHANIE S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
KLEIN MATTHEW B Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
SMITH MARY L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
YOUNG ALETHIA R. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
BELL WILLIAM F JR. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
GRAVIER PIERRE Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
SOUTHWELL DAVID P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
ZELDIS JEROME B. M.D., PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
BOULDING MARK ELLIOTT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
STEELE GLENN D JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
SCHMERTZLER MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
PAUWELS ERIC Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
ALMSTEAD NEIL GREGORY Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Feb 15, 2024 |
JACOBSON ALLAN STEVEN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
ALMSTEAD NEIL GREGORY Chief Technology Officer | Sale at price 27.25 per share. | Indirect | 17,604 | Jan 30, 2024 |
BOULDING MARK ELLIOTT Officer | Sale at price 27.25 per share. | Direct | 21,637 | Jan 30, 2024 |
PAUWELS ERIC Officer | Sale at price 27.25 per share. | Direct | 9,974 | Jan 30, 2024 |
UTTER CHRISTINE MARIE Officer | Sale at price 27.25 per share. | Direct | 8,666 | Jan 30, 2024 |
JACOBSON ALLAN STEVEN Director | Conversion of Exercise of derivative security at price 27.05 per share. | Direct | 270,500 | Jan 22, 2024 |
JACOBSON ALLAN STEVEN Director | Sale at price 27.38 per share. | Direct | 273,804 | Jan 22, 2024 |
ALMSTEAD NEIL GREGORY Chief Operating Officer | Sale at price 28.64 - 29.01 per share. | Indirect | 83,950 | Jan 9, 2024 |
GOLDEN LEE SCOTT Officer | Sale at price 28.64 - 29.01 per share. | Direct | 57,739 | Jan 9, 2024 |
BOULDING MARK ELLIOTT Officer | Sale at price 28.64 - 29.01 per share. | Direct | 97,960 | Jan 9, 2024 |
PAUWELS ERIC Officer | Sale at price 28.64 - 29.01 per share. | Direct | 104,852 | Jan 9, 2024 |
UTTER CHRISTINE MARIE Officer | Sale at price 28.64 - 29.01 per share. | Direct | 81,986 | Jan 9, 2024 |
KLEIN MATTHEW B Chief Executive Officer | Sale at price 28.64 - 29.01 per share. | Direct | 221,996 | Jan 9, 2024 |
SCHMERTZLER MICHAEL Director | Sale at price 27.81 per share. | Direct | 41,715 | Jan 8, 2024 |
KLEIN MATTHEW B Chief Executive Officer | Sale at price 27.15 per share. | Direct | 274,393 | Jan 5, 2024 |
KLEIN MATTHEW B Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 28, 2023 |
GRAVIER PIERRE Chief Financial Officer | Purchase at price 25.81 per share. | Direct | 198,736 | Dec 12, 2023 |
YOUNG ALETHIA R. Director | Conversion of Exercise of derivative security at price 27.85 per share. | Direct | 324,898 | Sep 6, 2023 |
YOUNG ALETHIA R. Director | Sale at price 39.79 - 39.90 per share. | Direct | 464,972 | Sep 6, 2023 |
JACOBSON ALLAN STEVEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 13, 2023 |
SCHMERTZLER MICHAEL Director | Sale at price 44.86 per share. | Direct | 44,860 | Jun 7, 2023 |
BELL WILLIAM F JR. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
REEVE EMMA Director | Conversion of Exercise of derivative security at price 33.02 - 33.63 per share. | Direct | 326,004 | May 23, 2023 |
REEVE EMMA Director | Sale at price 59.52 - 59.54 per share. | Direct | 581,515 | May 23, 2023 |
PAUWELS ERIC Officer | Sale at price 58.96 - 59.66 per share. | Direct | 496,282 | May 22, 2023 |
Related Tickers
AGIO Agios Pharmaceuticals, Inc.
45.66
+0.35%
RARE Ultragenyx Pharmaceutical Inc.
54.46
-3.20%
ASND Ascendis Pharma A/S
128.66
-0.95%
DYN Dyne Therapeutics, Inc.
33.48
-4.99%
MLTX MoonLake Immunotherapeutics
49.02
+0.16%
MGTX MeiraGTx Holdings plc
5.99
-2.44%
XENE Xenon Pharmaceuticals Inc.
44.21
-1.45%
AKRO Akero Therapeutics, Inc.
30.90
-1.06%
SWTX SpringWorks Therapeutics, Inc.
30.49
-1.55%
SLNO Soleno Therapeutics, Inc.
53.75
-0.76%